GTX medical is developing the Go-2 Targeted Epidural Spinal Stimulation (TESS) therapy, based upon the research from Prof. Grégoire Courtine from the Ecole Polytechnique Fédérale de Lausanne (EPFL) and Prof. Jocelyne Bloch from the Centre Hospitalier Universitaire Vaudois (CHUV) in Lausanne.
Our current focus is to improve leg function. The stimulation electrode will be inserted in the epidural space of the spinal cord at the lumbar level to cover the conus, hence above the spinal circuits controlling locomotion. In the future we aim to also treat arm and hand function. Promising advancements have been made in pre-clinical and early clinical research. Register below for more information on progress.